In the short term we are also expecting another deal with Big Pharma. This must be the CD40 ligand work - this could be of the order of the anti-microbials deal.
Near the end of the year we are expecting the second phase of the Roche deal.
PLUS - there is the potential for positive surprises in terms of new deals for discovery targets outside of existing discovery work (which is the reason the Roche deal was so significant).
Phylogica has brilliant prospects.
- Forums
- ASX - By Stock
- delivery 101
PYC
pyc therapeutics limited
Add to My Watchlist
1.89%
!
$1.30

In the short term we are also expecting another deal with Big...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M |
Open | High | Low | Value | Volume |
$1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $1.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.32 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 1.250 |
2 | 22000 | 1.220 |
2 | 2166 | 1.200 |
1 | 8474 | 1.180 |
1 | 6000 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 10000 | 1 |
1.330 | 3633 | 1 |
1.340 | 9300 | 1 |
1.420 | 26097 | 2 |
1.425 | 25000 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online